This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
Modern Healthcare
Research that was once focused on unlocking the secrets to prolonging life may now hold the key to halting or curbing two often-fatal blood disorders affecting bone marrow cells and clotting.
Two papers published online recently in the New England Journal of Medicine show promising results in the treatment of two rare blood disorders using an experimental therapy developed by Menlo Park, California, biopharmaceutical firm Geron Corp.
READ MORE
Advertisement
ACS
On Monday, Sept. 28, the American Cancer Society (ACS) in collaboration with the National Accreditation Program for Breast Centers (NAPBC) will host Genetic Testing 101: Identifying High Risk Individuals. This live 60-minute webinar will start at 12 p.m. ET. In order to participate in this webinar, you will need to register.
READ MORE
Agency for Healthcare Research and Quality
This statistical brief presents data from the Household Component of the Medical Expenditure Panel Survey regarding medical expenditures associated with the top five most costly conditions in 2002 and 2012. The top five conditions were determined by totaling and ranking the expenses for the medical care delivered for the diagnosis and treatment of acute and chronic conditions. Expenditures may be associated with more than one condition and are not unduplicated in the condition totals. Only differences between estimates that are statistically significant at the 0.05 level are discussed in the text. Dollar values are adjusted for inflation by using the gross domestic product implicit price deflator.
READ MORE
|
Promoted by
|
|
|
|
 |
Newsweek
Breast cancer much more commonly afflicts women — only about 1 percent of cases in the U.S. are diagnosed in men — but men are still at risk and face many of the same treatment decisions. Women and men who survive breast cancer all share the same fear: that they'll be diagnosed with it again in the future. This fear is why so many breast cancer patients choose to undergo contralateral prophylactic mastectomy, surgery to remove the healthy breast in addition to the breast with malignant tissue, to hopefully reduce the risk in a future diagnosis.
READ MORE
Medpage Today
Genetic and genomic testing for cancer susceptibility have introduced a new level of complexity to oncology practice, requiring appropriate education to ensure optimal use for patients, according to an updated policy statement from the American Society of Clinical Oncology.
READ MORE
 |
|
NCBC is certifying breast patient Navigators on every coast. If you’ve ever wanted to validate your skills in navigation, now is your chance. In November, a review course and a breast patient navigator exam will be offered on consecutive days in New York City and then later in Albuquerque, NM.
|
|
ACS
On Nov. 14, the National Accreditation Program for Breast Centers (NAPBC) will hold the Pursuing Excellence through NAPBC Accreditation workshop in Chicago at the American College of Surgeons' Headquarters. If you are applying for NAPBC accreditation or preparing for an initial or re-accreditation survey, this program is a must-attend. For more information, visit www.facs.org/napbcworkshop or email NAPBC@facs.org
READ MORE
Cancer Research UK via Medical Xpress
As tumors develop, faults can pop up in what seems like a bewildering number of genes. Each time one cell becomes two, these mistakes can change and become more diverse. But in some cases, the early events that lead to cancer can be readily identified. And for bowel cancer, scientific fingers have been pointing at one particular gene for almost 30 years.
READ MORE
 |
|
CHAMPS Oncology’s new web-based system transforms cancer data into actionable information for strategic planning, operational and financial decisions.
• CHAMPS Seeks i2o™ Early Adopters
• i2o™ Provides Answers to Cancer Service Lines’ Questions
• Access 75+ Cancer Data Reports (Migration, Utilization & More)
|
|
| NAPBC and CoC provide online poster to observe Breast Cancer Awareness Month
|
    |
ACS
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote the event and use it as an opportunity to display/promote your accreditation status. To help you publicize this event within your program and the community, the NAPBC and the CoC have created a poster that you can download and print. Programs that are solely CoC accredited or accredited by both the CoC and NAPBC can access the poster by logging into CoC Datalinks and clicking on Marketing Resources Staff and NAPBC-accredited breast centers can log into the NAPBC portal and click on the "2015 Breast Cancer Awareness Month Poster" link in the "View Downloadable Center Resources" section to access the marketing resources Web page. For more information, contact srubin@facs.org.
Fortune
The Broad Institute will use Google Cloud Engine's pre-emptible VMs, Cycle Computing's orchestration and machine learning to parse cancer cell and genetic data.
READ MORE
|
Promoted by
|
|
|
|
 |
Medical News Today
Immunotherapy has received a boost as a treatment approach for cancer, in light of research carried out by a group of international scientists led by a team at the University of California-San Francisco.
READ MORE
ACS
The American College of Surgeons (ACS) recently announced the launch of Surgery Career Connection, a new career center that connects surgeons across all disciplines and career stages with employers offering career opportunities. Surgery Career Connection is powered by YourMembership, the leading provider of job websites and career centers for organizations that serve specialized members.
READ MORE
ACS
Register to attend the ACS Clinical Congress in Chicago, Oct. 4-8, and you can preorder the Webcasts today. This year's Clinical Congress includes more than 15 panel sessions in the Surgical Oncology Track that cover a variety of topics. For detailed information, please visit the Clinical Congress 2015 Web page.
Note: Webcasts will be made available after Nov. 15. Purchase provides access to the 2015 Webcast sessions and expires Dec. 31, 2016.
READ MORE
Elsevier via Medical Xpress
Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role played by the biomarker microRNA-506 in gastric cancer. Patients whose primary gastric cancer lesions express high levels of miR-506 have significantly longer survival times compared with patients with low miR-506 expression. In addition, miR-506 suppresses tumor growth, blood vessel formation and metastasis.
READ MORE
HCP Live
Voriconazole, used to treat fungal infections in lung transplant recipients, has been reported to increase their risk of skin cancer and mortality.
Because transplant recipients require more intensive immunosuppression therapy, they are more likely to develop cutaneous squamous cell carcinoma — 65 times more likely than the general population.
READ MORE
Medical News Today
In a new study published in The American Journal of Pathology, scientists say they have identified a biomarker in patients with stomach cancer that starves tumors of their blood supply and reduces the ability of cancer cells to spread to other parts of the body.
READ MORE
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
